爱游戏平台注册登录

Introducing Revvity - Expanding the boundaries of human potential through science

(Revvity was previously affiliated with 爱游戏平台注册登录 , Inc.)

We are now two standalone organizations

Life Sciences & Diagnostics and Analytical & Enterprise Solutions

Newborn Screening Reagents

OF

Use the highest quality reagents available today to screen for core newborn disorders as well as those detected by expanded screening. Our reagents are the industry standard for analytical performance and reliability in detecting congenital diseases that are treatable only when identified during the first days of life.

Products & Services (45)
Filters:
Product Type
  • Consumables (3)
  • Reagents (42)
Application
  • Newborn Screening (42)
Product Brand Name
  • AutoDELFIA® (5)
  • EnLite (2)
  • GSP® (1)
  • GSP® (16)
  • Migele (1)
  • MSMS Kit (2)
  • NeoBase (1)
  • NeoBase 2 (3)
  • NeoBase™ (4)
  • NeoLSD™ (2)
  • VICTOR2 D (7)
Detection Method
  • DELFIA (16)
  • Electrophoresis (1)
  • Enzymatic (14)
  • Mass Spectrometry (MSMS) (9)
Sample Type
  • Dried blood spots (8)
  • Sample Collection Devices (3)
Automation Compatible
  • Yes (1)
Disorders
  • Biotinidase (BTD) Deficiency (3)
  • Congenital Adrenal Hyperplasia (CAH) (3)
  • Congenital Hypothyroidism (8)
  • Cystic Fibrosis (4)
  • Duchenne Muscular Dystrophy (1)
  • Fabry (2)
  • Galactosemia (6)
  • Gaucher (2)
  • Glucose-6-phosphate Dehydrogenase (G6PD) Deficiency (1)
  • Hemoglobinopathies (1)
  • Krabbe (2)
  • Metabolic Disorders (7)
  • MPS-I (2)
  • Niemann-Pick A/B (2)
  • Phenylketonuria (3)
  • Pompe (2)
  • SCID (2)
Format
  • Microplates (1)
Length
  • 0-10 (3)
Technology Type
  • MSMS (2)
Type
  • Card (3)

Sort by

1-25 of 45 Products & Services

  • NeoLSD MSMS Kit

    NeoLSD MSMS Kit

    The NeoLSD MSMS Kit is intended for the quantitative measurement of the activity of the enzymes acid-β-glucocerebrosidase (ABG), acid-sphingomyelinase (ASM), acid α glucosidase (GAA), β galactocerebrosidase (GALC), α-galactosidase A (GLA) and α-L-iduronidase (IDUA) in dried blood spots (DBS) from newborn babies.
  • 3044-0010 NeoBase™ 2 Non-derivatized MSMS kit

    NeoBase 2 Non-derivatized MSMS kit

    NeoBase 2 kit, The next generation in MSMS based newborn screening
  • NeoLSD MSMS Kit

    NeoLSD MSMS kit

    The NeoLSD MSMS Kit is intended for the quantitative measurement of the activity of the enzymes acid-β-glucocerebrosidase (ABG), acid-sphingomyelinase (ASM), acid α glucosidase (GAA), β galactocerebrosidase (GALC), α-galactosidase A (GLA) and α-L-iduronidase (IDUA) in dried blood spots (DBS) from newborn babies.
  • 3311-0010 GSP Creatine Kinease MM kit

    GSP Neonatal Creatine Kinase -MM kit

    The GSP Neonatal Creatine Kinase –MM kit is a solid phase, two-site fluoroimmunometric assay based on the direct sandwich technique. Analyte is bound to monoclonal CK-MM specific antibodies. The fluorescence signal is proportional to the analyte concentration in the sample.
  • 3046-0010 NeoBase™ 2 Succinylacetone Assay Solution

    NeoBase™ 2 Succinylacetone Assay Solution

    The NeoBase 2 Succinylacetone Assay Solution is intended for in vitro diagnostic use with the NeoBase 2 Non-derivatized MSMS kit (3044-0010) and the NeoBase 2 Non-derivatized Assay Solutions (3045-0010) to extract succinylacetone from blood samples dried on filter paper. Measurement of argininosuccinic acid requires use of NeoBase 2 Succinylacetone Assay Solution.
  • 3045-0010 NeoBase™ 2 Non-derivatized Assay Solutions

    NeoBase™ 2 Non-derivatized Assay Solutions

    The NeoBase 2 Non-derivatized Assay Solutions are intended for in vitro diagnostic use with the NeoBase 2 Non-derivatized MSMS kit (3044-0010) to extract target analytes from blood samples dried on filter paper and to carry target analytes to the MSMS system.
  • GSP Neonatal G6PD kit 3310-0010

    GSP® Neonatal G6PD kit

    GSP® Neonatal G6PD kits are intended for the semi-quantitative determination of glucose-6-phosphate dehydrogenase (G6PD) concentrations in blood specimens collected onto filter paper, as an aid in screening newborns for G6PD deficiency.
  • DX-Newborn-screening-kits_320px

    AutoDELFIA® Neonatal IRT KIT, WHATMAN 903

    This kit is intended for the quantitative determination of human immunoreactive trypsin(ogen) (IRT) in blood specimens dried on filter paper as an aid in screening newborns for cystic fibrosis using the 1235 AutoDELFIA® automatic immunoassay system.
  • EnLite 223

    EnLite Neonatal TREC kit

    The 爱游戏平台注册登录 EnLite Neonatal TREC kit, 1 x 384 reactions is an in vitro diagnostic product used with the VICTOR EnLite instrument for the semi-quantitative determination of TREC (T-cell receptor excision circle) DNA in blood specimens dried on filter paper.
  • EnLite 223

    EnLite Neonatal TREC kit, 4 x 96 reactions

    The 爱游戏平台注册登录 EnLite Neonatal TREC kit, 4 x 96 reactions is an in vitro diagnostic product used with the VICTOR EnLite instrument for the semi-quantitative determination of TREC (T-cell receptor excision circle) DNA in blood specimens dried on filter paper.
  • DX-Newborn-screening-kits_320px

    NeoBase Non-derivatized Assay Solutions

    The NeoBase MSMS kit is intended for the quantitative determination of up to 11 clinically significant amino acids and 31 clinically significant acylcarnitines, detecting more than 30 different metabolic diseases from a single dried blood spot sample using the MS/MS tandem mass spectrometer.
  • DX-Newborn-screening-kits_320px

    GSP® Neonatal Total Galactose kit

    Kit to determine Neonatal Total Galactose kit using the GSP platform.
  • DX-Newborn-screening-kits_320px

    GSP® Neonatal Phenylalanine kit

    Phenylketonuria (PKU) is a disorder of amino acid metabolism with reported incidence ranging from 1 in 19,000 to 1 in 13,500 newborn infants*. It is caused by an inability to convert phenylalanine to tyrosine due to deficient activity of the enzyme, phenylalanine hydroxylase.
  • DX-Newborn-screening-kits_320px

    GSP® Neonatal Biotinidase kit

    GSP Neonatal Biotinidase kit
  • DX-Newborn-screening-kits_320px

    GSP® Neonatal IRT kit

    The diagnosis of cystic fibrosis is often based on the symptoms, which may cause considerable delays in the disease intervention, and evidence indicates that early attention may be important in determining the clinical outcome.
  • DX-Newborn-screening-kits_320px

    GSP® Neonatal GALT kit

    GSP® GALT kit for detection of galactose.
  • DX-Newborn-screening-kits_320px

    GSP Neonatal 17α-OH-progesterone kit

    Congenital adrenal hyperplasia (CAH) is a genetic disorder and the most severe form of the disease can lead to a life threatening condition during the first weeks of life. The disease is caused by enzyme defects in steroid biosynthesis, the most frequent types being 21- and 11α-hydroxylase deficiency.
  • DX-Newborn-screening-kits_320px

    GSP® Neonatal Thyroxine (T4) kit

    Congenital hypothyroidism (CH) results from a failure of the thyroid glands to produce thyroid hormones in adequate amounts. The condition can easily be treated with daily doses of thyroid hormones but clinical diagnosis is difficult to establish and the disease may continue unrecognized for a long time causing irreversible brain damage.
  • DX-Newborn-screening-kits_320px

    GSP Neonatal hTSH kit

    Congenital hypothyroidism (CH) results from a failure of the thyroid glands to produce thyroid hormones in adequate amounts. The condition can easily be treated with daily doses of thyroid hormones but clinical diagnosis is difficult to establish and the disease may continue unrecognized for a long time causing irreversible brain damage.
  • DX-Newborn-screening-kits_320px

    Neonatal Phenylalanine kit (4800 test kit)

    Neonatal Phenylalanine kits are intended for the quantitative determination of phenylalanine in blood specimens dried on filter paper as an aid in identifying phenylketonuria in newborns.
  • Resolve kit

    RESOLVE Hemoglobin kit

    The RESOLVE Neonatal Hemoglobin test kit is designed to separate whole blood, cord blood or dried blood spot specimens for detection of normal and variant hemoglobins by isoelectric focusing.
  • DX-Newborn-screening-kits_320px

    Neonatal Phenylalanine kit (10 plate)

    Neonatal Phenylalanine kits are intended for the quantitative determination of phenylalanine in blood specimens dried on filter paper as an aid in identifying phenylketonuria in newborns.
  • Manual Neonatal GALT kit2

    Neonatal GALT kit

    Neonatal Galactose Transferase (GALT) kits are intended for the semi-quantitative determination of galactose-1-phosphate uridyltransferase (GALT) activity in blood specimens collected onto filter paper, in screening newborns for galactosemia.
  • DX-Newborn-screening-kits_320px

    Neonatal Total Galactose kit (10 plate)

    Neonatal Total Galactose kit is intended for the quantitative determination of total galactose (galactose and galactose-1-phosphate) concentrations in blood specimens dried on filter paper as an aid in screening newborns for galactosemia.
  • Newborn Screening kits

    Neonatal Biotinidase kit

    Neonatal Biotinidase kit is intended for the semi-quantitative determination of biotinidase activity in blood specimens dried on filter paper as an aid in screening newborns for biotinidase deficiency.
  • Jump to:
Baidu
map